Amundi lifted its position in shares of Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 479.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 454,095 shares of the software maker's stock after acquiring an additional 375,719 shares during the quarter. Amundi owned 0.77% of Manhattan Associates worth $60,449,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of MANH. Eagle Bay Advisors LLC purchased a new position in Manhattan Associates during the fourth quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd raised its stake in shares of Manhattan Associates by 448.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 137 shares of the software maker's stock worth $28,000 after buying an additional 112 shares during the period. BNP Paribas purchased a new position in shares of Manhattan Associates during the 4th quarter valued at approximately $39,000. TD Private Client Wealth LLC grew its stake in Manhattan Associates by 83.8% in the 4th quarter. TD Private Client Wealth LLC now owns 239 shares of the software maker's stock valued at $41,000 after acquiring an additional 109 shares during the period. Finally, V Square Quantitative Management LLC purchased a new stake in Manhattan Associates in the 4th quarter worth $44,000. Hedge funds and other institutional investors own 98.45% of the company's stock.
Insiders Place Their Bets
In other Manhattan Associates news, CEO Eric Andrew Clark sold 1,000 shares of the business's stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $146.77, for a total transaction of $146,770.00. Following the transaction, the chief executive officer owned 92,638 shares of the company's stock, valued at approximately $13,596,479.26. The trade was a 1.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP James Stewart Gantt sold 5,139 shares of the company's stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $195.53, for a total value of $1,004,828.67. Following the completion of the sale, the executive vice president owned 55,676 shares of the company's stock, valued at approximately $10,886,328.28. The trade was a 8.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.84% of the company's stock.
Key Headlines Impacting Manhattan Associates
Here are the key news stories impacting Manhattan Associates this week:
- Positive Sentiment: Manhattan Associates reported quarterly adjusted EPS of $1.39, exceeding the $1.32 consensus estimate, while revenue of $297.79 million surpassed expectations of $289.03 million and increased 9.3% year over year. Manhattan Associates Shares Gap Up After Strong Earnings
- Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $5.44–$5.50, well above the analyst consensus of $5.02. Revenue guidance was approximately $1.2 billion, broadly in line with expectations, suggesting the earnings boost is being driven primarily by profitability and operating leverage. Why Manhattan Associates Is Up After Raising 2026 Guidance
- Positive Sentiment: Robert W. Baird raised its price target for MANH to $218, reinforcing the view that cloud adoption and AI-related products can support further upside. Robert W. Baird Boosts Manhattan Associates Price Target
- Neutral Sentiment: Analysts and investors remain divided on whether the company’s next growth phase is already reflected in the stock’s valuation. Recent commentary highlights the potential of Manhattan’s “Editions” and AI-agent offerings but also recommends patience as these initiatives scale. Manhattan Associates: The Next Chapter Is Already Priced In
- Negative Sentiment: EVP James Stewart Gantt sold 5,139 shares for approximately $1.0 million, reducing his ownership by 8.45%. While the sale may be routine, insider selling can weigh modestly on investor sentiment after a sharp rally. SEC Insider Sale Filing
- Negative Sentiment: Rosen Law Firm announced an investigation into potential breaches of fiduciary duties by Manhattan Associates’ directors and officers. The announcement does not establish wrongdoing, but it introduces a legal and reputational overhang. Rosen Law Firm Announces Investigation
Manhattan Associates Price Performance
MANH opened at $191.36 on Monday. The firm has a market capitalization of $11.32 billion, a price-to-earnings ratio of 54.83 and a beta of 0.93. The company's 50 day simple moving average is $150.47 and its two-hundred day simple moving average is $145.27. Manhattan Associates, Inc. has a 1-year low of $119.06 and a 1-year high of $227.43.
Manhattan Associates (NASDAQ:MANH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The software maker reported $1.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.32 by $0.07. Manhattan Associates had a return on equity of 86.72% and a net margin of 18.67%.The business had revenue of $297.79 million during the quarter, compared to analyst estimates of $289.03 million. During the same period in the prior year, the business earned $1.31 earnings per share. The business's revenue was up 9.3% compared to the same quarter last year. On average, equities analysts anticipate that Manhattan Associates, Inc. will post 3.87 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. Morgan Stanley set a $180.00 target price on shares of Manhattan Associates in a research report on Wednesday. Citigroup upped their price target on shares of Manhattan Associates from $177.00 to $193.00 and gave the stock a "buy" rating in a research report on Tuesday, July 21st. Robert W. Baird raised their price target on shares of Manhattan Associates from $186.00 to $218.00 and gave the company an "outperform" rating in a research note on Wednesday, July 29th. Barclays lowered their price objective on Manhattan Associates from $239.00 to $201.00 and set an "overweight" rating on the stock in a report on Friday, May 29th. Finally, Stifel Nicolaus boosted their price objective on Manhattan Associates from $200.00 to $225.00 and gave the stock a "buy" rating in a research note on Wednesday. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $209.20.
Get Our Latest Stock Report on Manhattan Associates
About Manhattan Associates
(
Free Report)
Manhattan Associates, Inc NASDAQ: MANH is a provider of supply chain and omnichannel commerce software solutions designed to optimize the flow of goods, information and funds across enterprise operations. Its flagship offerings include warehouse management, transportation management, order management and omnichannel fulfillment applications. These solutions are delivered through a cloud-native platform called Manhattan Active, which enables retailers, manufacturers, carriers and third-party logistics providers to orchestrate inventory, manage distribution and improve customer service in real time.
Key product areas include Manhattan Active Warehouse Management, which automates and optimizes warehouse operations from receiving through shipping; Manhattan Active Transportation Management, supporting carrier selection, routing and freight payment; and Manhattan Active Omni, which unifies order capture, inventory visibility and fulfillment across stores, distribution centers and e-commerce channels.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Manhattan Associates, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Manhattan Associates wasn't on the list.
While Manhattan Associates currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.